Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces.
Coagulation kinetics are well established for purified blood proteases or human plasma clotting isotropically. However, less is known about thrombin generation kinetics and transport within blood clots formed under hemodynamic flow. Using microfluidic perfusion (wall shear rate, 200 s-1) of corn trypsin inhibitor-treated whole blood over a 250-μm long patch of type I fibrillar collagen/lipidated tissue factor (TF; ∼1 TF molecule/μm2), we measured thrombin released from clots using thrombin-antithrombin immunoassay. The majority (>85%) of generated thrombin was captured by intrathrombus fibrin as thrombin-antithrombin was largely undetectable in the effluent unless Gly-Pro-Arg-Pro (GPRP) was added to block fibrin polymerization. With GPRP present, the flux of thrombin increased to ∼0.5 × 10-12nmol/μm2-s over the first 500 s of perfusion and then further increased by ∼2-3-fold over the next 300 s. The increased thrombin flux after 500 s was blocked by anti-FXIa antibody (O1A6), consistent with thrombin-feedback activation of FXI. Over the first 500 s, ∼92,000 molecules of thrombin were generated per surface TF molecule for the 250-μm-long coating. A single layer of platelets (obtained with αIIbβ3antagonism preventing continued platelet deposition) was largely sufficient for thrombin production. Also, the overall thrombin-generating potential of a 1000-μm-long coating became less efficient on a per μm2basis, likely due to distal boundary layer depletion of platelets. Overall, thrombin is robustly generated within clots by the extrinsic pathway followed by late-stage FXIa contributions, with fibrin localizing thrombin via its antithrombin-I activity as a potentially self-limiting hemostatic mechanism.
From the Department of Chemical and Biomolecular Engineering, Institute of Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Shu
S
Zhu
From the Department of Chemical and Biomolecular Engineering, Institute of Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Yichen
Y
Lu
From the Department of Chemical and Biomolecular Engineering, Institute of Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Talid
T
Sinno
From the Department of Chemical and Biomolecular Engineering, Institute of Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104 sld@seas.upenn.edu.
Scott L
SL
Diamond
D001777:Blood Coagulation; D001792:Blood Platelets / Q000737:chemistry / Q000378:metabolism; D003094:Collagen / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D005337:Fibrin / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D009842:Oligopeptides / Q000737:chemistry / Q000378:metabolism; D013917:Thrombin / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D013925:Thromboplastin / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D013927:Thrombosis / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism
D009842:Oligopeptides; C034585:glycyl-prolyl-arginyl-proline; D005337:Fibrin; D003094:Collagen; D013925:Thromboplastin; D013917:Thrombin
antithrombin (AT); hemostasis; microfluidic; platelet; thrombin; thrombosis